These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 20022823
21. Long-term survival of peripheral intrahepatic cholangiocarcinoma with distant metastasis. Izumi R, Shimizu K, Kiriyama M, Yagi M, Matsui O, Nonomura A, Miyazaki I. Am J Gastroenterol; 1995 Mar; 90(3):505-7. PubMed ID: 7872300 [No Abstract] [Full Text] [Related]
23. Brachytherapy in the treatment of cholangiocarcinoma. Shinohara ET, Guo M, Mitra N, Metz JM. Int J Radiat Oncol Biol Phys; 2010 Nov 01; 78(3):722-8. PubMed ID: 20207503 [Abstract] [Full Text] [Related]
24. Expression of matrix metalloproteinase 7 is an unfavorable postoperative prognostic factor in cholangiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts. Itatsu K, Zen Y, Yamaguchi J, Ohira S, Ishikawa A, Ikeda H, Sato Y, Harada K, Sasaki M, Sasaki M, Sakamoto H, Nagino M, Nimura Y, Ohta T, Nakanuma Y. Hum Pathol; 2008 May 01; 39(5):710-9. PubMed ID: 18329694 [Abstract] [Full Text] [Related]
25. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus. Sano T, Shimada K, Sakamoto Y, Ojima H, Esaki M, Kosuge T. Ann Surg Oncol; 2008 Feb 01; 15(2):590-9. PubMed ID: 18057991 [Abstract] [Full Text] [Related]
26. Cholangiocarcinoma: the "other" liver cancer on the rise. Davila JA, El-Serag HB. Am J Gastroenterol; 2002 Dec 01; 97(12):3199-200. PubMed ID: 12492212 [No Abstract] [Full Text] [Related]
27. Clinical value of additional resection of a margin-positive proximal bile duct in hilar cholangiocarcinoma. Shingu Y, Ebata T, Nishio H, Igami T, Shimoyama Y, Nagino M. Surgery; 2010 Jan 01; 147(1):49-56. PubMed ID: 19767048 [Abstract] [Full Text] [Related]
28. The incidence of cholangiocarcinoma in primary sclerosing cholangitis after long-time treatment with ursodeoxycholic acid. Rudolph G, Kloeters-Plachky P, Rost D, Stiehl A. Eur J Gastroenterol Hepatol; 2007 Jun 01; 19(6):487-91. PubMed ID: 17489059 [Abstract] [Full Text] [Related]
29. Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance. Shimonishi T, Isse K, Shibata F, Aburatani I, Tsuneyama K, Sabit H, Harada K, Miyazaki K, Nakanuma Y. Hepatology; 2000 Oct 01; 32(4 Pt 1):761-9. PubMed ID: 11003620 [Abstract] [Full Text] [Related]
30. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors). Schmitz KJ, Lang H, Kaiser G, Wohlschlaeger J, Sotiropoulos GC, Baba HA, Jasani B, Schmid KW. Hum Pathol; 2009 Dec 01; 40(12):1706-14. PubMed ID: 19683330 [Abstract] [Full Text] [Related]
31. Prognosis and treatment of bile duct carcinoma. Chung C, Bautista N, O'Connell TX. Am Surg; 1998 Oct 01; 64(10):921-5. PubMed ID: 9764692 [Abstract] [Full Text] [Related]
32. [Retrospective analysis of 830 extrahepatic biliary carcinoma]. Shi J, Zhou L, Wang Z. Zhonghua Wai Ke Za Zhi; 1997 Nov 01; 35(11):645-8. PubMed ID: 10678003 [Abstract] [Full Text] [Related]
33. Left hemihepatectomy and caudate lobectomy and complete extrahepatic bile duct resection using transduodenal approach for hilar cholangiocarcinoma arsing from biliary papillomatosis. Kim JK, Hwang HK, Park JS, Cho SI, Yoon DS, Chi HS. J Surg Oncol; 2008 Aug 01; 98(2):139-42. PubMed ID: 18521837 [Abstract] [Full Text] [Related]
34. [Review: analysis of survival rate and prognostic factors of intrahepatic cholangiocarcinoma: 318 cases in single institute]. Lee WJ, Park JW. Korean J Hepatol; 2007 Jun 01; 13(2):125-8. PubMed ID: 17585185 [No Abstract] [Full Text] [Related]
35. Epidemiology of intrahepatic, perihilar, and distal cholangiocarcinoma in the French population. Al Mahjoub A, Bouvier V, Menahem B, Bazille C, Fohlen A, Alves A, Mulliri A, Launoy G, Lubrano J. Eur J Gastroenterol Hepatol; 2019 Jun 01; 31(6):678-684. PubMed ID: 30633038 [Abstract] [Full Text] [Related]
36. Extrahepatic cholangiocarcinoma: current surgical strategy. Boutros C, Somasundar P, Espat NJ. Surg Oncol Clin N Am; 2009 Apr 01; 18(2):269-88, viii. PubMed ID: 19306812 [Abstract] [Full Text] [Related]
37. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis. Hanazaki K, Kajikawa S, Shimozawa N, Shimada K, Hiraguri M, Koide N, Adachi W, Amano J. Hepatogastroenterology; 2002 Apr 01; 49(44):311-6. PubMed ID: 11995440 [Abstract] [Full Text] [Related]
38. Carcinoma of the extrahepatic biliary tree: analysis of 15 cases. Mena FJ, Velicia R, Valbuena MC, González JM, Caro-Patón A, Pérez-Miranda M, Bellido J. Rev Esp Enferm Dig; 1999 Apr 01; 91(4):297-304. PubMed ID: 10447345 [Abstract] [Full Text] [Related]
39. Phenotypic diversity of intrahepatic and extrahepatic cholangiocarcinoma on aspiration cytology and core needle biopsy: case series and review of the literature. Chaudhary HB, Bhanot P, Logroño R. Cancer; 2005 Aug 25; 105(4):220-8. PubMed ID: 15952192 [Abstract] [Full Text] [Related]
40. Endoscopic sphincterotomy and long-term risk of cholangiocarcinoma: a population-based follow-up study. Mortensen FV, Jepsen P, Tarone RE, Funch-Jensen P, Jensen LS, Sørensen HT. J Natl Cancer Inst; 2008 May 21; 100(10):745-50. PubMed ID: 18477806 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]